Dyadic International (DYAI) Current Leases (2023 - 2026)
Dyadic International's (DYAI) quarterly Current Leases came in at $19998.0 in Q1 2026, down 64.22% year-over-year from $55895.0 in Q1 2025, and down 42.24% quarter-over-quarter from $34621.0 in Q4 2025.
Analysis
Dyadic International (DYAI) Current Leases (2023 - 2026) Analysis & Trends
Dyadic International has disclosed Current Leases across 4 years of filings, most recently posting $19998.0 for Q1 2026.
- In Q1 2026, Current Leases fell 64.22% year-over-year to $19998.0; the TTM figure through Mar 2026 stood at $19998.0 (down 64.22% YoY), while the FY2025 annual figure was $34621.0, down 36.18% from the prior year.
- Current Leases came in at $19998.0 for Q1 2026 at Dyadic International, down from $34621.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $57577.0 in Q2 2025 to a low of $19998.0 in Q1 2026.
- Average Current Leases over 4 years is $47275.2, with a median of $49551.0 recorded in 2024.
- Year-over-year, Current Leases advanced 14.76% in 2024 and tumbled 64.22% in 2026.
- Over 4 years, Current Leases stood at $48059.0 in 2023, then grew by 12.88% to $54249.0 in 2024, then sank by 36.18% to $34621.0 in 2025, then tumbled by 42.24% to $19998.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $19998.0 in Q1 2026, $34621.0 in Q4 2025, and $48927.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 720.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 11.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 12.38 Mn |
| 10 | Dyadic International | 17.78 Mn | 9.82 Mn | - | 19,998.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 19,998.00 |
| Dec 31, 2025 | 34,621.00 |
| Sep 30, 2025 | 48,927.00 |
| Jun 30, 2025 | 57,577.00 |
| Mar 31, 2025 | 55,895.00 |
| Dec 31, 2024 | 54,249.00 |
| Sep 30, 2024 | 53,476.00 |
| Jun 30, 2024 | 51,075.00 |
| Mar 31, 2024 | 49,551.00 |
| Dec 31, 2023 | 48,059.00 |
| Sep 30, 2023 | 46,599.00 |